Deerfield Management Company, L.P. (Series C) Care Dx, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.38 Billion
- Q3 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Care Dx, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 30,871 shares of CDNA stock, worth $653,539. This represents 0.02% of its overall portfolio holdings.
Number of Shares
30,871Holding current value
$653,539% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CDNA
# of Institutions
219Shares Held
51.1MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$112 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$96 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$66.6 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$63.3 Million0.89% of portfolio
-
State Street Corp Boston, MA2.04MShares$43.1 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.13B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...